
    
      An open label, multi-centre, non-interventional post-marketing surveillance (PMS) to monitor
      the safety and effectiveness of Nebivolol administered in Korean patients according to the
      prescribing information

      Nebivolol will be administered to Hypertension or Chronic heart failure (CHF) patients as
      described the prescribing information of Nebivolol by physician's decision.
    
  